Trump Plans High Tariffs on Generic Drugs Starting in 2028
📊 ABBV — Piyasa Yorumu
▼ down · 60%The news reports on Trump's plan to impose high customs tariffs on generic drugs. This could increase costs for pharmaceutical companies such as ABBV and negatively impact their profitability. Technical indicators show RSI at 60 and MACD below the signal line, signaling short-term weakness. Although the stock is above the 20-day moving average, the uncertainty created by the news may lead to selling pressure. Therefore, a downward movement is expected in the short term.
📊 CVS — Piyasa Yorumu
▼ down · 70%Trump's plan to impose high customs tariffs on generic drugs could increase global trade tensions and suppress risk appetite. This news may create short-term selling pressure, particularly in emerging markets and economies dependent on drug imports, such as Turkey. Markets may adopt a cautious stance amid concerns over renewed trade wars and cost inflation. However, the impact is likely to be limited, as the plan is spread over a long timeline, such as 2028.